The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report. A report from 3 Axis Advisors ...

The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report.

Immunic Inc (NASDAQ:IMUX, FRA:10VA) said on Tuesday the European Patent Office has granted a key patent covering dosing regimens for its experimental multiple sclerosis treatment vidofludimus calcium, ...

A genetic mutation tied to keeping the brain healthy at high altitudes may point to a way to repair nerve damage, experiments in mice show.

TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health ...

By Jonathan Stempel NEW YORK, March 9 (Reuters) - A federal judge ruled on Monday that JPMorgan Chase employees may pursue part of their lawsuit accusing the largest U.S. bank of mismanaging its ...

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

Alzheimer’s disease, or AD, is a terrible illness that is currently affecting 7.2 million adults in the United States. The Alzheimer’s Association predicts that without improved medical research and t ...

During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts I am eager to see ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), ...

Multiple sclerosis (MS) is a chronic, disabling, inflammatory disease that damages your nerves. People with MS typically live roughly seven years less than the general population, with an average life ...